Overview
Kosei Kageyama practices in Kajigaya, Japan. Mr. Kageyama is rated as an Advanced expert by MediFind in the treatment of Sepsis. His top areas of expertise are Febrile Neutropenia, Agranulocytosis, Sepsis, Primary Lymphoma of the Brain, and Bone Marrow Transplant.
His clinical research consists of co-authoring 33 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 10 articles in the study of Sepsis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AgranulocytosisMr. Kageyama isAdvanced. Learn about Agranulocytosis.
- Bone Marrow TransplantMr. Kageyama isAdvanced. Learn about Bone Marrow Transplant.
- Febrile NeutropeniaMr. Kageyama isAdvanced. Learn about Febrile Neutropenia.
- SepsisMr. Kageyama isAdvanced. Learn about Sepsis.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Mr. Kageyama isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloid Leukemia (AML)Mr. Kageyama isExperienced. Learn about Acute Myeloid Leukemia (AML).
- B-Cell LymphomaMr. Kageyama isExperienced. Learn about B-Cell Lymphoma.
- Coronary Artery SpasmMr. Kageyama isExperienced. Learn about Coronary Artery Spasm.
- Follicular LymphomaMr. Kageyama isExperienced. Learn about Follicular Lymphoma.
- Graft Versus Host Disease (GvHD)Mr. Kageyama isExperienced. Learn about Graft Versus Host Disease (GvHD).